Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc (ADAP) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
adap · market cap & enterprise value · FMP · as of Nov 21, 2025
Core market cap & key metrics
As of Nov 21, 2025, Adaptimmune Therapeutics plc (ADAP) has a market cap — also referred to as its net worth or valuation — of $75,157,679, making it one of the top most valuable companies globally. Market Cap = $0.05 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Adaptimmune Therapeutics plc (ADAP) has a market cap — also referred to as its net worth or valuation — of $75,157,679 as of Nov 21, 2025, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Adaptimmune Therapeutics plc reached its all-time high market cap of $22.5B on Sep 7, 2021. Comparing the Adaptimmune Therapeutics plc market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Adaptimmune Therapeutics plc net worth vs peers and ask how Adaptimmune Therapeutics plc valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
ADAP market cap · 6 questionsAdaptimmune Therapeutics plc's net worth — measured as market capitalization — is $75,157,679 as of Nov 21, 2025. It ranks #0 globally. Market Cap = $$0.05 (price) × shares outstanding.